Antigen receptor‐engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice
Jelka Pohar(Inserm), Simon Fillatreau(Hôpital Necker-Enfants Malades), Pierre Boudinot(Université de Versailles Saint-Quentin-en-Yvelines), Richard A. O’Connor(Queen's Medical Centre), Mario Bunse(Helmholtz Association of German Research Centres), Mohamed El Behi(Centre National de la Recherche Scientifique), Benoît Manfroi(Centre National de la Recherche Scientifique), Roland Liblau(Université Toulouse III - Paul Sabatier), Marine Luka(Inserm), Mickaël Ménager(Inserm), Wolfgang Uckert(Sorbonne Université), Stephen M. Anderton(Centre for Inflammation Research), Luc Jouneau(Institut National de la Recherche Agronomique)
Cited by 12
Related Papers
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
B cells regulate autoimmunity by provision of IL-10
|Nature Immunology|2002|1.6k
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
|Nature|2014|1k
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
|The Journal of Experimental Medicine|2012|651
Antibody-independent functions of B cells: a focus on cytokines
|Nature reviews. Immunology|2015|511